Consolidated Statement of Operations - USD ($)	3 Months Ended
	Jan. 31, 2021	Jan. 31, 2020
Details
Revenues	$ 1,697,921	$ 4,225,315
Operating expenses:
Cost of revenues	569,673	2,286,066
Research and development expenses	47,632	112,303
Selling, general, and administrative expenses	678,819	2,168,350
Operating Expenses	1,296,124	4,566,719
Income/(Loss) from operations	401,797	(341,404)
Interest expense - related party	266,400	210,286
Income/(loss) before income taxes	135,397	(551,690)
Provision for income taxes	0	31,560
Net income/(loss)	$ 135,397	$ (583,250)
Net income/(loss) per common share - basic	$ 0.02	$ (0.08)
Net income/(loss) per common share - diluted	$ 0.02	$ (0.08)
Weighted average number of common shares outstanding - basic	7,712,091	7,706,004
Weighted average number of common shares outstanding - diluted	7,712,091	7,706,004